Alterations in gut microbiota affect behavioral and inflammatory responses to methamphetamine in mice.

Abstract

RATIONALE AND OBJECTIVES:

Methamphetamine (METH) is a highly addictive and widely abused drug that causes severe neuroinflammation in the human brain. The gut microbiota has a tremendous impact on the core symptoms of neuropsychiatric disorders via the microbiota-gut-brain (MGB) axis. However, it is not clear whether alterations in the gut microbiota are involved in METH exposure.

METHODS:

We established a mouse model with chronic, escalating doses of METH exposure. Intervene in gut microbiota with antibiotics to observe the changes of locomotor activity caused by METH exposure in mice. qPCR and 16S rRNA gene sequencing were used to analyze the gut microbiota profiles. In addition, we tested the levels of inflammatory factors in the nucleus accumbens (NAc), prefrontal cortex (mPFC), hippocampus (HIp), and spleen. Finally, short-chain fatty acids (SCFAs) were supplemented to determine the interaction between behavior changes and the structure of gut microbiota.

RESULTS:

In this research, METH increased the locomotor activity of mice, while antibiotics changed the effect. Antibiotics enhanced the expression of pro-inflammatory cytokines in mPFC, HIp, and spleen of METH-exposed mice. METH altered the gut microbiota of mice after antibiotic treatment, such as Butyricicoccus and Roseburia, which are related to butyrate metabolism. Supplementation with SCFAs changed the behavior of METH-exposed mice and decreased Parabacteroides and increased Lactobacillus in METH-exposed mice gut.

CONCLUSIONS:

This research showed that antibiotics affected the behavior of METH-exposed mice and promoted inflammation. Our findings suggest that SCFAs might regulate METH-induced gut microbiota changes and behavior.

• Authors: Simin Lai, Jing Wang, Biao Wang, Rui Wang, Guodong Li, Yuwei Jia, Teng Chen, Yanjiong Chen
• Journal: Psychopharmacology (Psychopharmacology (Berl)) Vol. 239 Issue 8 Pg. 1-16 (Aug 2022) ISSN: 1432-2072 [Electronic] Germany
• PMID: 35503371 (Publication Type: Journal Article)
• Copyright: © 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Chemical References

• Anti-Bacterial Agents
• RNA, Ribosomal, 16S
• Methamphetamine

Topics

• Animals
• Anti-Bacterial Agents
• Gastrointestinal Microbiome
• Humans
• Methamphetamine (pharmacology)
• Mice
• Mice, Inbred C57BL
• RNA, Ribosomal, 16S